About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5911579
Allelic
Composition		 Col1a1tm2(tetO-GFP/RNAi:Smc1a)Iaai/Col1a1tm3(tetO-GFP/RNAi:Stag2)Iaai
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
Genetic
Background		 involves: 129S4/SvJae * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Col1a1tm2(tetO-GFP/RNAi:Smc1a)Iaai mutation (0 available); any Col1a1 mutation (166 available)
Col1a1tm3(tetO-GFP/RNAi:Stag2)Iaai mutation (0 available); any Col1a1 mutation (166 available)
Gt(ROSA)26Sortm1(rtTA*M2)Jae mutation (31 available); any Gt(ROSA)26Sor mutation (1098 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
hematopoietic system
abnormal definitive hematopoiesis ( J:229031 )
• lineage skewing is seen following short term doxycycline exposure
myeloid hyperplasia ( J:229031 )
• develops over time
anemia ( J:229031 )
• develops over time
decreased B cell number ( J:229031 )
• decrease in the proportion of B cell population (B220+) develops over time
abnormal spleen morphology ( J:229031 )
• disrupted morphology
enlarged spleen ( J:229031 )
• following short term doxycycline exposure

immune system
myeloid hyperplasia ( J:229031 )
• develops over time
decreased B cell number ( J:229031 )
• decrease in the proportion of B cell population (B220+) develops over time
abnormal spleen morphology ( J:229031 )
• disrupted morphology
enlarged spleen ( J:229031 )
• following short term doxycycline exposure

growth/size/body
enlarged spleen ( J:229031 )
• following short term doxycycline exposure

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
03/25/2025
MGI 6.24 		The Jackson Laboratory